Fig. 7
From: Spatially fractionated GRID radiation potentiates immune-mediated tumor control
WTRT success relies on maximizing log-cell kill. A Average fold change of effector population in responding or non-responding mIHC slide 12 tumors treated with 2 Gy × 35 of WTRT. B Distribution of clearance times for responding tumors in A. C, D Contribution of effector-mediated cancer cell death, treatment, and apoptosis in the 7 day or 1 day period leading up to and including clearance of tumors treated with WTRT respectively. Error bars are mean \(\pm\) SEM. (*** p < 0.001, two-sided Wilcoxon rank sum test, Table S7)